Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-078084
Filing Date
2024-07-05
Accepted
2024-07-05 16:01:13
Documents
1
Group Members
JUVVENTURES (UK) LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2418833d1_sc13da.htm SC 13D/A 45070
  Complete submission text file 0001104659-24-078084.txt   46797
Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Subject) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90737 | Film No.: 241102609
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1ST FLOOR, VIKING HOUSE ST PAULS SQUARE, RAMSEY Y8 IM8 1GB
Business Address 1ST FLOOR, VIKING HOUSE ST PAULS SQUARE, RAMSEY Y8 IM8 1GB 441624639396
Juvenescence Ltd (Filed by) CIK: 0001724307 (see all company filings)

EIN.: 000000000 | State of Incorp.: Y8 | Fiscal Year End: 1231
Type: SC 13D/A